✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

CSL Ltd

Common Name
CSL
Country
Australia
Sector
Healthcare
Industry
Biotechnology
Employees
29,904
Ticker
CSL
Exchange
Australian Securities Exchange
Description
CSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s port...

CSL's GHG Emissions Data Preview

In 2026, CSL completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, CSL has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2026202520242023-2019
Total Scope 1
134,731,000,000a
134,810,000,000a
132,840,000,000a
Total Scope 2
Market-Based
103,482,000,000a
151,590,000,000a
215,090,000,000a
Location-Based
213,156,000,000a
229,250,000,000a
248,620,000,000a
Total Scope 3
1,281,000a
N/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
8,582,685.6924a
8,736,876.2152a
9,042,886.3172a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=CSL&reporting_period=2026"

Verified Sources Behind CSL’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. CSL's Annual Report 2026
b. CSL's Annual Report 2023

Insights into CSL's Operational Emissions

In 2026, the total operational greenhouse gas (GHG) emissions of CSL amounted to 347,887,000,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2025, the total operational greenhouse gas (GHG) emissions of CSL decreased by 4.44%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

CSL's Scope 1 Emissions Over Time

20222023202420252026035 B70 B105 B140 BtCO2e+9%+117557422%+1%0%
  • Total Scope 1
  • Year-over-Year Change

What are CSL's Scope 1 emissions?

In 2026, the total Scope 1 emissions of CSL were 134,731,000,000 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2025), CSL's Scope 1 emissions remained relatively stable, indicating that CSL's emissions have plateaued with no significant change in its operational footprint.a

What are CSL's Scope 2 emissions?

In 2026, CSL reported Scope 2 greenhouse gas (GHG) emissions of 103,482,000,000 tCO₂e using the market-based method and 213,156,000,000 tCO₂e using the location-based method.a

Has CSL reduced its Scope 2 emissions over time?

Compared to the previous year (2025), CSL's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that CSL's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does CSL use for Scope 2 reporting?

In 2026, CSL reported its Scope 2 emissions using the market-based method and using the location-based method.a

CSL's Scope 2 Emissions Over Time

20222023202420252026065 B130 B195 B260 BtCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into CSL's Value Chain Emissions

In 2026, CSL reported 1,281,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2026 disclosure of CSL includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2025, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

CSL's Scope 3 Emissions Over Time

202120260600 k1.2 M1.8 M2.4 MtCO2e-44%
  • Total Scope 3
  • Year-over-Year Change

What are CSL's Scope 3 emissions?

In 2026, CSL reported total Scope 3 emissions of 1,281,000 metric tons of CO₂ equivalent (tCO₂e).a

Has CSL reduced its Scope 3 emissions over time?

Since 2021, CSL's Scope 3 emissions have decreased by 43.91%, reflecting a declining long-term trend in Scope 3 emissions over time.ab

Insights into CSL’s GHG Emissions Intensity Compared to Industry Peers

In 2026, CSL reported Scope 1 greenhouse gas (GHG) emissions of 134,731,000,000 tCO₂e and total revenues of USD 15,698 millions. This translates into an emissions intensity of 8,582,685.69 tCO₂e per millions USD.a

CSL's Scope 1 Emissions Intensity Compared to Peers

2010,0005,000,0002,000,000,0002,000,000,000,000Scope 1 Emissions (tCO2e)502001,0005,00050,000Revenues (Millions of USD)RemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MCytokineticsYear: 2025Scope 1: 294 tCO2eRevenue: $M 88Scope 1 Intensity: 3.34 tCO2e/$MIonis PharmaceuticalsYear: 2025Scope 1: 2,615 tCO2eRevenue: $M 944Scope 1 Intensity: 2.77 tCO2e/$MSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 217Scope 1 Intensity: 29.23 tCO2e/$MAkesoYear: 2025Scope 1: 6,623 tCO2eRevenue: $M 437Scope 1 Intensity: 15.17 tCO2e/$MJazz PharmaceuticalsYear: 2025Scope 1: 4,758 tCO2eRevenue: $M 4,268Scope 1 Intensity: 1.11 tCO2e/$MSino BiopharmaceuticalYear: 2024Scope 1: 18,239 tCO2eRevenue: $M 3,955Scope 1 Intensity: 4.61 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,559Scope 1 Intensity: 14.99 tCO2e/$MAscendis PharmaYear: 2025Scope 1: 69 tCO2eRevenue: $M 847Scope 1 Intensity: 0.08 tCO2e/$MargenxYear: 2025Scope 1: 2,120 tCO2eRevenue: $M 4,154Scope 1 Intensity: 0.51 tCO2e/$MInnovent BiologicsYear: 2025Scope 1: 7,803 tCO2eRevenue: $M 1,863Scope 1 Intensity: 4.19 tCO2e/$MGenmabYear: 2025Scope 1: 758 tCO2eRevenue: $M 586Scope 1 Intensity: 1.29 tCO2e/$MBiontechYear: 2025Scope 1: 2,209 tCO2eRevenue: $M 3,374Scope 1 Intensity: 0.65 tCO2e/$MInsmedYear: 2025Scope 1: 2,622 tCO2eRevenue: $M 606Scope 1 Intensity: 4.32 tCO2e/$MIncyteYear: 2025Scope 1: 8,872 tCO2eRevenue: $M 5,141Scope 1 Intensity: 1.73 tCO2e/$MModernaYear: 2025Scope 1: 10,463 tCO2eRevenue: $M 1,922Scope 1 Intensity: 5.44 tCO2e/$MCelltrionYear: 2024Scope 1: 27,147 tCO2eRevenue: $M 2,424Scope 1 Intensity: 11.20 tCO2e/$MAlnylam PharmaceuticalsYear: 2025Scope 1: 6,785 tCO2eRevenue: $M 3,714Scope 1 Intensity: 1.83 tCO2e/$MSamsung BiologicsYear: 2024Scope 1: 71,972 tCO2eRevenue: $M 3,099Scope 1 Intensity: 23.22 tCO2e/$MBeOne MedicinesYear: 2025Scope 1: 11,539 tCO2eRevenue: $M 5,343Scope 1 Intensity: 2.16 tCO2e/$MRegeneron PharmaceuticalsYear: 2025Scope 1: 89,990 tCO2eRevenue: $M 14,343Scope 1 Intensity: 6.27 tCO2e/$MVertex PharmaceuticalsYear: 2025Scope 1: 12,296 tCO2eRevenue: $M 12,001Scope 1 Intensity: 1.02 tCO2e/$MUcbYear: 2025Scope 1: 22,194 tCO2eRevenue: $M 9,101Scope 1 Intensity: 2.44 tCO2e/$MCSLYear: 2026Scope 1: 134,731,000,000 tCO2eRevenue: $M 15,698Scope 1 Intensity: 8,582,685.69 tCO2e/$M

How does CSL's GHG emissions intensity compare to its peers?

In 2026, CSL reported a Scope 1 emissions intensity of 8,582,685.69 tCO₂e per millions USD. Compared to the peer group median of 3.06, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does CSL rank on GHG emissions intensity within its industry?

In 2026, CSL ranked 25 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places CSL among the least efficient performers, with one of the highest emissions intensities in its sector.a

Insights into CSL's Total Carbon Footprint

In 2026, CSL reported a total carbon footprint of 347,888,281,000 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 4.44% decrease compared to 2025, indicating progress in reducing its overall greenhouse gas output.a

The largest contributor to CSL's total carbon footprint was Scope 2 emissions, accounting for 61.27% of the company's total carbon footprint, followed by Scope 1 emissions at 38.73%.a

Want Full Access to CSL's GHG Emissions Dataset?
Start 30-Day Free Trial